<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03103100</url>
  </required_header>
  <id_info>
    <org_study_id>F140903008</org_study_id>
    <nct_id>NCT03103100</nct_id>
  </id_info>
  <brief_title>Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation</brief_title>
  <official_title>Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation: A Prospective, Randomized, Double-Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare and determine the most ideal local anesthetic (LA) solution to
      activate a labor epidural: lidocaine, bupivacaine, or a combination of bupivacaine plus
      lidocaine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most common and effective method for controlling labor pains is a local anesthetic (LA)
      infusion through a lumbar epidural. To achieve adequate pain control during the first stage
      of labor - onset of contractions to complete cervical dilation - nerve fibers up to the T10
      dermatome must be anesthetized. When a patient is in active labor and an epidural catheter is
      placed, the anesthesiologist must activate the epidural by administering LA through the
      epidural to promote spread of the LA in the epidural space to anesthetize the nerve fibers
      involved in the conduction of labor pains. The ideal LA to achieve this goal is one that
      would allow for the fastest onset to achieve quick pain relief with the fewest side effects.

      Two commonly used LA to provide labor analgesia are bupivacaine and lidocaine. When low
      concentrations - 0.25% bupivacaine and 1% lidocaine - are used for labor analgesia, both of
      these LA can be administered safely with very little concern of major adverse effects
      associated with LA toxicity. Given that there is limited and conflicting evidence for the
      usefulness of the bupivacaine and lidocaine mixture especially as it relates to labor
      epidural activation, we hope to readdress these questions in an effort to determine whether
      or not the LA combination offers any distinct advantage over the individual LA. The
      investigators intend to determine the time it takes to achieve an adequate level (T10) for
      labor analgesia, the total spread of local anesthetic, and the degree of motor block as these
      factors will be important in determining the most optimal LA solution to activate a labor
      epidural. With the results from this study, the investigators hope to recommend a LA solution
      that will allow for the fastest pain relief in the laboring mother with the fewest side
      effects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 8, 2015</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to achieve an adequate epidural level for labor analgesia</measure>
    <time_frame>Baseline to 1 hour</time_frame>
    <description>time it takes to achieve a T10 dermatome level by pinprick</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Spread</measure>
    <time_frame>Baseline to 1 hour</time_frame>
    <description>the total spread (both cephalad and caudal) of the LA (dermatome level to be determined by pin prick and ice),</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of motor block</measure>
    <time_frame>Baseline to 1 hour</time_frame>
    <description>onset and degree of motor block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of maternal hypotension</measure>
    <time_frame>Baseline to 1 hour</time_frame>
    <description>incidence of maternal hypotension defined as a BP &gt;20% decline from baseline and need for vasopressor therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fetal status</measure>
    <time_frame>Baseline to 1 hour</time_frame>
    <description>any change in fetal status by monitoring FHR.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>1% Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized into the lidocaine group will receive 10 mL of 1% lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.25% Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized into the bupivacaine group will receive 10 mL of 0.25% bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine plus Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized into the bupivacaine group will receive 5 mL of 0.25% bupivacaine and 5 mL of 1% lidocaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1% Lidocaine</intervention_name>
    <description>10 mL of 1% lidocaine</description>
    <arm_group_label>1% Lidocaine</arm_group_label>
    <other_name>Lidoderm, Xylocaine, Recticare, Anecream,</other_name>
    <other_name>Solarcaine, Anestacon, Cutiecaine, Lidocoll,</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25% Bupivacaine</intervention_name>
    <description>10 mL of 0.25% bupivacaine</description>
    <arm_group_label>0.25% Bupivacaine</arm_group_label>
    <other_name>Marcaine and Sensorcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine plus Lidocaine</intervention_name>
    <description>5 mL of 1% lidocaine and 5 mL of 0.25% bupivacaine</description>
    <arm_group_label>Bupivacaine plus Lidocaine</arm_group_label>
    <other_name>Lidoderm, Xylocaine, Recticare, Anecream, Lmx4, Akten,</other_name>
    <other_name>Marcaine and Sensorcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant patients over the age of 19 who are scheduled for an induction of labor and
             request an epidural are eligible for the study

        Exclusion Criteria:

          -  age &lt;19

          -  allergy to the drug or drug class

          -  preexisting neuropathy

          -  history of back pain prior to pregnancy or history of back surgery

          -  history of chronic opioid use

          -  history of hypertension or hypertensive disorders of pregnancy

          -  congenital or acquired cardiac disease

          -  contraindication to epidural placement (patient refusal, severe coagulopathy,
             infection at site of epidural needle insertion, severe hypovolemia)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Healthy females admitted for induction of labor</gender_description>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark F Powell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alicia Kindred, MS</last_name>
    <phone>205-934-4711</phone>
    <email>aliciakindred@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ayesha Bryant, MD</last_name>
    <phone>205-996-7383</phone>
    <email>asbryant@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UAB Department of Anesthesiology and Perioperative Medicine</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicia Kindred, MS</last_name>
      <phone>205-934-4711</phone>
      <email>aliciakindred@uabmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ayesha Bryant, MSPH, MD</last_name>
      <phone>205-996-7383</phone>
      <email>asbryant@uabmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Powell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Froelich, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Promil Kukreja, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2017</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2017</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Mark Powell</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Local anesthetic</keyword>
  <keyword>Labor epidural</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

